PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Phoxillum B22k 4/0 In Plastic Container, and when can generic versions of Phoxillum B22k 4/0 In Plastic Container launch?
Phoxillum B22k 4/0 In Plastic Container is a drug marketed by Baxter Hlthcare Corp and is included in one NDA.
The generic ingredient in PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate. There are two hundred and eighty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate profile page.
Summary for PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Mayo Clinic | Phase 4 |
See all PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER clinical trials
Pharmacology for PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
Anatomical Therapeutic Chemical (ATC) Classes for PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
US Patents and Regulatory Information for PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare Corp | PHOXILLUM B22K 4/0 IN PLASTIC CONTAINER | calcium chloride; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride; sodium phosphate | INJECTABLE;INJECTION | 207026-002 | Jan 13, 2015 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
